Top news from MedWatch this week
Miss anything?
Monday
Pharma giants see huge potential in new "super technology" for fighting a wide range of diseases
Novo Nordisk buys treatment candidate for rare disease for up to USD 1.2bn
Analyst: Biden attack on pharmaceutical industry seems symbolic
Tuesday
Experts: The world needs more than just mRNA vaccines
Janssen gets FDA approval for new Darzalex combination
Wednesday
Dane overcomes Tokyo culture shock to run Lundbeck's most successful launch
Thursday
Genmab surpasses 1,000 employees
Friday
With launches on the way in the US and EU, MC2 turns attention to the rest of its pipeline
GN Hearing shrinks again and Denmant's growth proves short-lived on VA channel
.jpg&w=384&q=75)
